Enzyme-Linked Immunosorbent Assay (ELISA) Market Size| 2022-27
Market Overview:
During the anticipated period, the Enzyme-Linked Immunosorbent Assay (ELISA) market is anticipated to grow at a CAGR of 8%. (2022–2027).
Enzyme-Linked Immunosorbent Assay (ELISA) demand has increased due to the COVID-19 all over the world. The main cause of this is the rise in infection rates, which increased the demand for accurate diagnosis. Data from the National Center for Biotechnology Information (NCBI) Journal in 2020 show that SARS-CoV-2 can be accurately detected using the enzyme-linked immunosorbent assay (ELISA). The demand for more affordable and accurate diagnoses in order to receive the right treatment is anticipated to fuel market expansion.
Scope of the Report:
The Enzyme-Linked Immunosorbent Assay (ELISA), which is covered by the scope of this report, is a frequently used solid-phase type enzyme immunoassay for detecting the presence of a ligand in a liquid sample using antibodies against the protein to be measured. The Enzyme-Linked Immunosorbent Assay (ELISA) market is divided into four categories: product (Direct ELISA, Indirect ELISA, Sandwich ELISA, and Competitive ELISA), application (Disease Diagnosis, Vaccine development, and Others), geography (North America, Europe, Asia-Pacific, Middle East, and Africa), and category. The market report also includes an analysis of 17 countries across the world’s major regions’ estimated market sizes and trends. The report provides values for the aforementioned segments in (in USD million).
Comments
Post a Comment